Tag:
Motrin
Latest Headlines
Latest Headlines
J&J ramping up OTC production as 'decree' work allows
Alex Gorsky, in his first earnings call since taking the CEO spot at Johnson & Johnson, listed a lot of priorities--there is a lot to be fixed at the pharmaceutical and consumer products company--but getting over-the-counter products like Tylenol and Motrin back into the hands of consumers remains his number one "short term priority."
J&J pulls infant Tylenol on dosing-system issue
Johnson & Johnson's consumer healthcare unit is recalling another children's Tylenol product. This time, it's not manufacturing failures spurring the recall, but a dosing system that...
Lawsuit blames J&J quality problems for child's death
A Washington couple is suing Johnson & Johnson ( $JNJ ) over the death of their 2-year-old son, claiming the company didn't do enough to warn patients about quality-control problems with its
J&J pulls 12M Motrin bottles as recalls lawsuit gets green light
In the sort of coincidental timing that suggests that the universe has an ironic sense of humor, Johnson & Johnson ( $JNJ ) has recalled 12 million bottles of Motrin, just as an investor lawsuit
Baby 'halo' saves J&J brand from recalls, legal woes
Has any drugmaker suffered more tarballs to its good name than Johnson & Johnson ( $JNJ ) over the past year? Recalls, lawsuits, government probes, guilty pleas--it's been one negative headline
Jury orders J&J to pay $10M in Motrin injury case
A Philadelphia jury levied a $10 million judgment against Johnson & Johnson in a liability lawsuit over its Motrin fever and pain reliever. After deliberating for 10 hours, the jury decided to
J&J on trial for lack of warnings on kids' drugs
Johnson & Johnson failed to warn parents that its Children's Motrin and Children's Tylenol pain relievers can cause severe allergic reactions, a lawyer for the family of a girl allegedly injured
Oregon sues J&J over 'phantom' Motrin recall
Johnson & Johnson's recall scandal has surfaced again. The state of Oregon has sued J&J over that so-called "phantom" recall of faulty Motrin tablets, saying that the company's delay in
Children's drug consumers sue J&J for fraud
Consumers are accusing Johnson & Johnson ( NYSE: JNJ ) of fraud and racketeering in a lawsuit stemming from its recent children's drug recall. The buyers of those recalled meds are demanding cash
J&J suffers 65% drop in pain-reliever sales
There have been a lot of predictions about Johnson & Johnson's ( NYSE: JNJ ) suffering reputation in the wake of highly public consumer-drug recalls. But Advertising Age has some numbers. J&J's
